![Cover Image for System.Linq.Enumerable+EnumerablePartition`1[System.Char]](https://coverimages.igi-global.com/images/search-article.png)
The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinoma.
David J Pinato, Rohini Sharma, Elias Allara, Clarence Yen, Tadaaki Arizumi, Keiichi Kubota, Dominik Bettinger, Jeong Won Jang, Carlo Smirne, Young Woon Kim, Masatoshi Kudo, Jessica Howell, Ramya Ramaswami, Michela E Burlone, Vito Guerra, Robert Thimme, Mitsuru Ishizuka, Justin Stebbing, Mario Pirisi, Brian I Carr
OAI: oai:www.repository.cam.ac.uk:1810/294090 • DOI: 10.17863/CAM.41191
Abstract
ALBI Albumins Bilirubin Biomarkers Carcinoma Hepatocellular Liver Failure Prognosis Retrospective Studies Adult Aged Bilirubin Biomarkers Tumor Carcinoma Hepatocellular Chemoembolization Therapeutic Europe Female Humans Liver Liver Failure Liver Neoplasms Male Middle Aged Neoplasm Staging Organ Dysfunction Scores Prognosis Reproducibility of Results Serum Albumin Survival Analysis